Form 4 for JNJ Johnson & Johnson
Accepted 2022-02-17 06:01:16 ET · period of report 2022-02-14 · accession 0001225208-22-002377 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | M - OptEx | $0.00 | +18.1K | 135.3K | +15% | $0 |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | F - Tax | $165.89 | -8,841 | 126.5K | -7% | -$1.47M |
| DM | 2022-02-17 06:01 | 2022-02-14 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | A - Grant | $157.90 | +84.1K | 4,053 | New | +$13.28M |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | M - OptEx | $0.00 | -18.1K | 1,721 | -91% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-15 | M | A | 18,064 | $0.00 | 135,297.00 | D | — | — | (F1) Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting. |
| 2 | Common | Common Stock | 2022-02-15 | F | D | 8,841 | $165.89 | 126,456.00 | D | — | — | (F2) Shares withheld for payment of taxes upon vesting of Performance Share Units. |
| 3 | Derivative | Employee Stock Options (Right to Buy) | 2022-02-14 | A | A | 80,055 | $165.89 | 80,055 | D | — · 2025-02-14 to 2032-02-14 | 80,055 Common Stock | (F3) Awarded under Issuer's Long-Term Incentive Plan. (F3) Awarded under Issuer's Long-Term Incentive Plan. |
| 4 | Derivative | Restricted Share Units | 2022-02-14 | A | A | 4,053 | $0.00 | 4,053 | D | — · 2025-02-14 to — | 4,053 Common Stock | (F4) Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. (F4) Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. |
| 5 | Derivative | Performance Share Units | 2022-02-15 | M | D | 18,064 | $0.00 | 1,721 | D | — · 2022-02-11 to — | 18,064 Common Stock | (F5) Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited. (F5) Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019. A portion of these Performance Share Units have been forfeited. |